nach oben

Japanese Journal of Radiology

Erschienen in:

18.04.2017 | Review

¹¹C-methionine PET/CT findings in benign brain disease

verfasst von: Reiko Nakajima, Ken Kimura, Koichiro Abe, Shuji Sakai

Erschienen in: Japanese Journal of Radiology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

¹¹C-methionine (MET) is one of the most commonly used positron emission tomography (PET) tracers for evaluation of malignant brain tumor, with MET-PET being a sensitive technique for visualization of primary and recurrent malignant brain tumors. However, previous reports have demonstrated MET uptake in lesions associated with benign brain diseases. These diseases usually show an increase in MET uptake similar to that of malignant tumors. This pitfall in MET-PET image interpretation is important not only for nuclear medicine professionals, but also for radiologists. In this review, we demonstrate the imaging characteristics of MET uptake in benign brain disease, and recommend physician interpretation of imaging findings and disease characteristics for optimal patient management. Benign uptake must be identified to prevent misdiagnosis and unnecessary surgical operations.

van Waarde A, Elsinga PH. Proliferation markers for the differential diagnosis of tumor and inflammation. Curr Pharm Des. 2008;14:3326–39.CrossRefPubMed

Ishiwata K, Kubota K, Murakami M, Kubota R, Sasaki T, Ishii S, et al. Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med. 1993;34:1936–43.PubMed

Omidi Y, Barar J. Impacts of blood–brain barrier in drug delivery and targeting of brain tumors. Bioimpacts. 2012;2:5–22.PubMedPubMedCentral

Shinozaki N, Uchino Y, Yoshikawa K, Matsutani T, Hasegawa A, Saeki N, et al. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of ¹¹C-methionine positron emission tomography. J Neurosurg. 2011;114:1640–7.CrossRefPubMed

Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, et al. Metabolic assessment of gliomas using ¹¹C-methionine, [¹⁸F] fluorodeoxyglucose, and ¹¹C-choline positron-emission tomography. AJNR. 2008;29:1176–82.CrossRefPubMed

Ito K, Matsuda H, Kubota K. Imaging spectrum and pitfalls of (11)C-methionine positron emission tomography in a series of patients with intracranial lesions. Korean J Radiol. 2016;17:424–34.CrossRefPubMedPubMedCentral

Harada Y, Hirata K, Kobayashi H, Usui R, Shiga T, Terae S, et al. A pitfall of C-11 methionine PET cerebral venous infarction mimicked a glioma. Clin Nucl Med. 2012;37:110–1.CrossRefPubMed

Nakagawa M, Kuwabara Y, Sasaki M, Koga H, Chen T, Kaneko O, et al. ¹¹C-methionine uptake in cerebrovascular disease: a comparison with ¹⁸F-fDG PET and ^99mTc-HMPAO SPECT. Ann Nucl Med. 2002;16:207–11.CrossRefPubMed

Nagano-Saito A, Kato T, Wakabayashi T, Nishino M, Ohshima M, Ito K, et al. High- and moderately high-methionine uptake demonstrated by PET in a patient with a subacute cerebral infarction. Ann Nucl Med. 2001;15:387–91.CrossRefPubMed

10.

Jacobs A. Amino acid uptake in ischemically compromised brain tissue. Stroke. 1995;26:1859–66.CrossRefPubMed

11.

Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Umemura K. Indications for differential diagnosis of nontumor central nervous system diseases from tumors. A positron emission tomography study. J Neuroimaging. 1997;7:8–15.CrossRefPubMed

12.

Dethy S, Goldman S, Blecic S, Luxen A, Levivier M, Hildebrand J. Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. J Nucl Med. 1994;35:1162–6.PubMed

13.

Ogawa T, Hatazawa J, Inugami A, Murakami M, Fujita H, Shimosegawa E, et al. Cardon-11-Methionine PET evaluation of intracerebral ematoma: distinguishing neoplastic from non-neoplastic hematoma. JNM. 1995;36:2175–9.PubMed

14.

Arita H, Kinoshita M, Okita Y, Hirayama R, Watabe T, Ishohashi K, et al. Clinical characteristics of meningiomas assessed by ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron-emission tomography. J Neurooncol. 2012;107:379–86.CrossRefPubMed

15.

Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, et al. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J Neurosurg. 2003;98:1056–64.CrossRefPubMed

16.

Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, et al. Diagnostic accuracy of ¹¹C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med. 2008;49:694–9.CrossRefPubMed

17.

Faria Dde P, Copray S, Buchpiguel C, Dierckx R, de Vries E. PET imaging in multiple sclerosis. J. Neuroimmune Pharmacol. 2014;4:468–82.CrossRef

18.

Padma MV, Adineh M, Pugar K, Mukherjee J, Satter M, Shi B, et al. Functional imaging of a large demyelinating lesion. J. Clin. Neurosci. 2005;12:176–8.CrossRefPubMed

19.

Matsuzono K, Deguchi K, Hishikawa N, Yamashita T, Ichikawa T, Date I, et al. Tumefactive demyelinating disease mimicking malignant tumor in positron emission tomography with ¹¹C-mithionine. Neurol Clin Neurosci. 2015;3:81–3.CrossRef

20.

Maeda Y, Oguni H, Saitou Y, Mutoh A, Imai K, Osawa M, et al. Rasmussen syndrome: multifocal spread of inflammation suggested from MRI and PET findings. Epilepsia. 2003;44:1118–21.CrossRefPubMed

21.

Morooka M, Kubota K, Minamimoto R, Furuhata M, Abe T, Ito K, et al. ¹⁸F-FDG and ¹¹C-methionine PET/CT findings in a case with anti-NMDA (NR2B) receptor encephalitis. Clin Nucl Med. 2012;37:400–2.CrossRefPubMed

22.

Hirata K, Shiga T, Fujima N, Manabe O, Usui R, Kuge Y, et al. ¹¹C-Methionine positron emission tomography may monitor the activity of encephalitis. Acta Radiol. 2012;53:1155–7.CrossRefPubMed

23.

Tsuyuguchi N, Sunada I, Ohata K, Takami T, Nishio A, Hara M, et al. Evaluation of treatment effects in brain abases with positron emission tomography. Ann Nucl Med. 2003;17:47–51.CrossRefPubMed

24.

Uda T, Tsuyuguchi N, Terakawa Y, Takami T, Ohata K. Evaluation of the accumulation of ¹¹C-methionine with standardized uptake value in the normal brain. J Nucl Med. 2010;51:219–22.CrossRefPubMed

25.

Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D. Ultrastructural and Immunocytochemical evidence that an incompetent blood-brain barrier is related to the Pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry. 2001;71:188–92.CrossRefPubMedPubMedCentral

26.

Naito K, Yamagata T, Arima H, Abe J, Tsuyuguchi N, Ohata K, et al. Qualitative analysis of spinal intramedullary lesionsusing PET/CT. J Neurosurg Spine. 2015;23:613–9.CrossRef

27.

Planas AM, Prenant C, Mazoyer BM, Comar D, Di Giamberardino L. Regional cerebral L-[¹⁴C-methyl]methionine incorporation into proteins: evidence for methionine recycling in the rat brain. J Cereb Blood Flow Metab. 1992;12:603–12.CrossRefPubMed

28.

Glaudemans AW, Enting RH, Heesters MA, Dierckx RA, van Rheenen RW, Walenkamp AM, et al. Value of ¹¹C-methionine PET in imaging brain tumours and metastases. Eur J Nucl Med Mol Imaging. 2013;40:615–35.CrossRefPubMed

29.

Ninomiya S, Hara M, Morita A, Teramoto H, Momose M, Takahashi T, et al. Tumefactive demyelinating lesion differentiated from a brain tumor using a combination of magnetic resonance imaging and ¹¹C-methionine positron emission tomography. Intern Med. 2015;54:1411–4.CrossRefPubMed

30.

Schiepers C, VanHecke P, Vandenberghe R, Van Oostende S, Dupont P, Demaerel P, et al. Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis. Mult Scler. 1997;3:8–17.CrossRefPubMed

Titel: 11C-methionine PET/CT findings in benign brain disease
verfasst von: Reiko Nakajima
Ken Kimura
Koichiro Abe
Shuji Sakai
Publikationsdatum: 18.04.2017
Verlag: Springer Japan
Erschienen in: Japanese Journal of Radiology / Ausgabe 6/2017
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI: https://doi.org/10.1007/s11604-017-0638-7

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

¹¹C-methionine PET/CT findings in benign brain disease

Abstract

Neu im Fachgebiet Radiologie

Akuter Schwindel: Wann lohnt sich eine MRT?

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2017

Comparison between the four-field box and field-in-field techniques for conformal radiotherapy of the esophagus using dose–volume histograms and normal tissue complication probabilities

Diffuse-type gastric cancer: specific enhancement pattern on multiphasic contrast-enhanced computed tomography

Contour variations of the body and tail of the pancreas: evaluation with MDCT

Successful percutaneous treatment of extrahepatic cystic echinococcosis through PAIR and single puncture catheter techniques

Usefulness of 2D fusion of postmortem CT and antemortem chest radiography studies for human identification

Modifying the planning target volume to optimize the dose distribution in dynamic conformal arc therapy for large metastatic brain tumors

Neu im Fachgebiet Radiologie

Akuter Schwindel: Wann lohnt sich eine MRT?

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Radiologie